Effective Plant-Based Cancer Treatment Solutions

Introduction

This innovative phytochemotherapy technology introduces a novel approach to cancer treatment using plant-based compounds, or phytochemicals, to target and destroy cancer cells. These natural compounds offer a promising alternative or complement to traditional chemotherapy, with the potential to reduce side effects and improve patient outcomes. For pharmaceutical companies and biotech firms focused on oncology, this technology provides a new pathway for developing cancer therapies that align with the growing demand for more effective and less harmful treatment options.

The Challenge: Managing Cancer Treatment Side Effects

While chemotherapy remains a key component of cancer treatment, its toxicity and severe side effects pose significant challenges for patients. Traditional chemotherapy treatments, which use powerful chemicals to kill cancer cells, often damage healthy cells in the process, leading to symptoms such as nausea, fatigue, and weakened immune response. There is an increasing need for cancer treatments that are both effective and less harmful, offering a better quality of life for patients while still targeting cancer cells aggressively. Plant-based therapies, known for their bioactive properties, offer an untapped resource for developing such treatments.

Phytochemicals for Targeted Cancer Therapy

This phytochemotherapy technology harnesses the power of naturally occurring phytochemicals, which have been shown to have anti-cancer properties. The method uses specific plant compounds to inhibit the growth of cancer cells, reduce tumor size, and improve overall patient health. By focusing on natural agents that selectively target cancer cells while sparing healthy tissue, this treatment can reduce the toxicity and side effects typically associated with chemotherapy. This makes it a potentially safer and more tolerable option for patients undergoing cancer treatment, especially for those seeking integrative or alternative therapies.

Key Benefits for Pharmaceutical and Oncology Sectors

Pharmaceutical companies stand to benefit from this plant-based cancer treatment by developing new drugs that appeal to patients seeking alternatives to traditional chemotherapy. This technology opens up a range of possibilities for combination therapies, where plant-based agents can enhance the effectiveness of existing treatments while mitigating adverse side effects. Oncology researchers will also find value in exploring the diverse range of bioactive compounds available in plants, leading to new insights and innovations in cancer therapy. Healthcare providers can offer patients more personalized and less aggressive treatment plans that prioritize both efficacy and well-being.

Invest in Next-Generation Cancer Therapies

Licensing this plant-based cancer treatment technology allows your organization to lead in the development of safer, more effective cancer therapies. By offering a natural alternative to traditional chemotherapy, this technology aligns with the growing demand for holistic and integrative medical treatments. It provides an opportunity to advance oncology care with innovative solutions that reduce the burden of side effects while maintaining the effectiveness of cancer treatment. This technology is a valuable investment for companies committed to improving patient outcomes and advancing cancer research.

The present invention provides for a novel anti-neoplastic pharmaceutical composition. Specifically, the present invention provides for phytochemotherapeutic compositions produced from aqueous extracts (and fractions thereof), derived from Vernonia amygdalina leaves. These pharmaceutical compositions inhibit the growth of neoplastic cells, including human breast cancer cells. Furthermore, the instant invention provides for methods of producing the compositions and methods of using the compositions to inhibit the proliferation of neoplastic cells.
1. A pharmaceutical composition comprising one or more purified polypeptide(s), the polypeptide(s) comprising the sequence(s) of SEQ ID NO:1 and/or SEQ ID NO:2.
2. The pharmaceutical composition of claim 1 wherein the polypeptide is isolated from a natural source or chemically synthesized.
3. The pharmaceutical composition of claim 2 wherein the polypeptide is purified from Vernonia amygdalina leaves.
4. The pharmaceutical composition of claim 2 wherein the polypeptide is chemically synthesized.
5. The pharmaceutical composition of claim 1 wherein the polypeptide(s) consists of the sequence of SEQ ID NO:1 and/or SEQ ID NO:2.
6. The pharmaceutical composition of claim 1 comprising a purified polypeptide comprising the sequence of SEQ ID NO:1.
7. The pharmaceutical composition of claim 1 comprising a purified polypeptide comprising the sequence of SEQ ID NO:2.
8. A method of treating an animal afflicted with a neoplastic disease comprising administering to the animal an effective amount of a pharmaceutical composition comprising one or more purified polypeptide(s), the polypeptide(s) comprising the sequence(s) of SEQ ID NO:1 and/or SEQ ID NO:2.
9. The method of claim 8 where the polypeptide is isolated from a natural source or chemically synthesized.
10. The method of claim 9 wherein the polypeptide is purified from Vernonia amygdalina leaves.
11. The method of claim 9 wherein the polypeptide is chemically synthesized.
12. The method of claim 8 wherein the purified polypeptide comprises the sequence of SEQ ID NO:1.
13. The method of claim 8 wherein the purified polypeptide comprises the sequence of SEQ ID NO:2.
14. The method of claim 8 wherein the animal is human.
15. The method of claim 8 wherein the neoplastic disease is breast cancer.
16. The method of claim 8 wherein the purified polypeptide consists of the sequence of SEQ ID NO:1.
17. The method of claim 8 wherein the purified polypeptide consists of the sequence of SEQ ID NO:2.

Share

Title

Phytochemotherapy for cancer

Inventor(s)

Ernest B. Izevbigie

Assignee(s)

Jackson State University

Patent #

6849604

Patent Date

February 1, 2005

Inquire about this intellectual property

Learn more about "Effective Plant-Based Cancer Treatment Solutions"